Renal cell carcinoma of end-stage renal disease: A histopathologic and molecular genetic study

被引:0
|
作者
Hughson, MD
Schmidt, L
Zbar, B
Daugherty, S
Meloni, AM
Silva, FG
Sandberg, AA
机构
[1] NCI, FREDERICK CANC RES & DEV CTR, BIOL CARCINOGENESIS & DEV PROGRAM, FREDERICK, MD 21701 USA
[2] NCI, FREDERICK CANC RES & DEV CTR, IMMUNOBIOL LAB, FREDERICK, MD 21701 USA
[3] SW BIOMED RES INST, SCOTTSDALE, AZ USA
[4] UNIV OKLAHOMA, HLTH SCI CTR, DEPT PATHOL, OKLAHOMA CITY, OK USA
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 1996年 / 7卷 / 11期
关键词
renal cell carcinoma; cancer genetics; ESRD;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Renal cell carcinomas (RCC) are responsible for the deaths of 3% to 4% of patients with ESRD. The clear cell carcinoma of the kidney, which comprises 80% of sporadic RCC within the general population, shows a deletion of gene sequences in the short arm of chromosome 3 (3p) in as many as 100% of cases. The von Hippel-Lindau tumor suppressor gene at 3p25-26 is found to be mutated in the nondeleted allele in 57% of these sporadic clear cell carcinomas. This study was undertaken to determine the histopathologic types of RCC occurring in ESRD patients in the United States and to investigate the frequency with which 3p genetic changes can be found in these ESRD tumors. Seventeen end-stage kidneys containing RCC were collected from 15 ESRD patients at ten US medical centers. The tumors were classified by Thoenes' histopathologic typing. DNA extracted from paraffin blocks of tumor and nontumorous tissue was analyzed by single-stranded conformational polymorphism analysis for von Hippel-Lindau mutations and by microsatellite amplification for deletion of 3p gene sequences. Twenty-one RCC were identified in the 18 kidneys, The 21 RCC were classified histopathologically as follows: clear cell, compact, three cases; chromophilic, tubulopapillary, 15 cases; chromophilic, compact, three cases. Among the three clear cell carcinomas, one showed 3p genetic loss, None of the chromophilic RCC showed a 3p deletion and none of 19 tumors studied by single-stranded conformational polymorphism analysis disclosed von Hippel-Lindau mutations. In contrast to the general population, clear cell RCC with 3p abnormalities represent only a small proportion of the renal carcinomas in this collection of ESRD tumors. The findings indicate that the genetic changes underlying the development of most ESRD tumors are different from those occurring in sporadic clear cell RCC and do not characteristically involve the inactivation of a 3p tumor suppressor gene.
引用
收藏
页码:2461 / 2468
页数:8
相关论文
共 50 条
  • [1] Renal Cell Carcinoma in End-Stage Renal Disease: A Review and Update
    El-Zaatari, Ziad M.
    Truong, Luan D.
    BIOMEDICINES, 2022, 10 (03)
  • [2] Synchronous tubulocystic cell carcinoma and papillary renal cell carcinoma in end-stage renal disease
    Henriques, V.
    Silva, A.
    Ferreira, M.
    VIRCHOWS ARCHIV, 2016, 469 : S335 - S335
  • [3] Renal cell carcinoma in end-stage renal disease: A retrospective study in patients from Hungary
    Semjen, David
    Denes, Borbala
    Somoracz, Aron
    Fintha, Attila
    Forika, Gertrud
    Jenei, Alex
    Dobi, Dejan
    Micsik, Tamas
    Eizler, Kornelia
    Giba, Nandor
    Santa, Fanni
    Sejben, Anita
    Ivanyi, Bela
    Kuthi, Levente
    PATHOBIOLOGY, 2023, 90 (05) : 322 - 332
  • [4] Genomic profiling of renal cell carcinoma in patients with end-stage renal disease
    Inoue, Toru
    Matsuura, Keiko
    Yoshimoto, Taichiro
    Lam Tung Nguyen
    Tsukamoto, Yoshiyuki
    Nakada, Chisato
    Hijiya, Naoki
    Narimatsu, Takahiro
    Nomura, Takeo
    Sato, Fuminori
    Nagashima, Yoji
    Kashima, Kenji
    Hatakeyama, Shingo
    Ohyama, Chikara
    Numakura, Kazuyuki
    Habuchi, Tomonori
    Nakagawa, Masayuki
    Seto, Masao
    Mimata, Hiromitsu
    Moriyama, Masatsugu
    CANCER SCIENCE, 2012, 103 (03) : 569 - 576
  • [5] THE ESTABLISHMENT OF HISTOLOGY FOR RENAL CELL CARCINOMA IN END-STAGE OF RENAL DISEASE IN JAPAN
    Sassa, Naoto
    Hattori, Ryohei
    Yoshino, Yasushi
    Tsuzuki, Toyonori
    Nishikimi, Toshinori
    Katsuno, Akira
    Fukatsu, Akitoshi
    Fujita, Takashi
    Ohmae, Kensi
    Gotoh, Momokazu
    JOURNAL OF UROLOGY, 2009, 181 (04): : 248 - 248
  • [6] GENOMIC PROFILING OF RENAL CELL CARCINOMA IN PATIENTS WITH END-STAGE RENAL DISEASE
    Inoue, Toru
    Matsuura, Keiko
    Yoshimoto, Taichiro
    Narimatsu, Takahiro
    Sato, Fuminori
    Nagashima, Yoji
    Hatakeyama, Shingo
    Ohyama, Chikara
    Habuchi, Tomonori
    Nakagawa, Masayuki
    Moriyama, Masatsugu
    Mimata, Hiromitsu
    JOURNAL OF UROLOGY, 2011, 185 (04): : E48 - E48
  • [7] Unilateral renal cell carcinoma with coexistent renal disease:: a rare cause of end-stage renal disease
    Peces, R
    Alvarez-Navascués, R
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (02) : 291 - 294
  • [8] Genetic factors in end-stage renal disease
    Satko, SG
    Freedman, BI
    Moossavi, S
    KIDNEY INTERNATIONAL, 2005, 67 : S46 - S49
  • [9] Genetic susceptibility to end-stage renal disease
    Schelling, JR
    Zarif, L
    Sehgal, A
    Iyengar, S
    Sedor, JR
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 1999, 8 (04): : 465 - 472
  • [10] Outcome of advanced renal cell carcinoma arising in end-stage renal disease: comparison with sporadic renal cell carcinoma
    Hiroki Ishihara
    Hironori Fukuda
    Hidekazu Tachibana
    Kazuhiko Yoshida
    Hirohito Kobayashi
    Toshio Takagi
    Junpei Iizuka
    Hideki Ishida
    Yoji Nagashima
    Tsunenori Kondo
    Kazunari Tanabe
    Clinical and Experimental Nephrology, 2021, 25 : 674 - 682